Palisade Bio, Inc.
PALI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357459
In the last 90 days, Palisade Bio, Inc. insiders filed 3 open-market purchases and 2 sales; 124 institutions reported holding it in 13F filings for Q2 2026, worth $362.4M in total; no superinvestor holds it.
Holders of 5% or more of PALI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Palisade Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G | 9.99%14.9M shares | New | Dec 8, 20251 filing | Dec 8, 2025 | SEC |
| Perceptive Advisors LLC | 13G | 9.99%12.2M shares | New | Oct 9, 20251 filing | Oct 9, 2025 | SEC |
| Deep Track Capital, LP | 13G | 9.99%10.0M shares | New | Oct 8, 20251 filing | Oct 8, 2025 | SEC |
| Ra Capital Management, L.P. | 13G | 9.90%9.94M shares | New | Oct 9, 20251 filing | Oct 9, 2025 | SEC |
| Commodore Capital LP | 13G | 9.90%9.69M shares | New | Oct 8, 20251 filing | Oct 8, 2025 | SEC |
| Squadron Capital Management LLC | 13G | 8.50%8.25M shares | New | Oct 8, 20251 filing | Oct 8, 2025 | SEC |
| Point72 Asset Management, L.P. | 13G | 6.20%7.59M shares | New | Oct 7, 20251 filing | Oct 7, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on Palisade Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 8, 202511:46 AM ET | Janus Henderson Group PLCand 1 other | 13G | 9.99%14.9M shares | New | Nov 28, 2025 | SEC |
| Oct 9, 20254:28 PM ET | Ra Capital Management, L.P.and 3 others | 13G | 9.90%9.94M shares | New | Oct 2, 2025 | SEC |
| Oct 9, 20254:00 PM ET | Perceptive Advisors LLCand 2 others | 13G | 9.99%12.2M shares | New | Oct 2, 2025 | SEC |
| Oct 8, 20254:12 PM ET | Squadron Capital Management LLCand 3 others | 13G | 8.50%8.25M shares | New | Oct 1, 2025 | SEC |
| Oct 8, 20254:09 PM ET | Commodore Capital LPand 3 others | 13G | 9.90%9.69M shares | New | Oct 1, 2025 | SEC |
| Oct 8, 20254:05 PM ET | Deep Track Capital, LPand 3 others | 13G | 9.99%10.0M shares | New | Oct 1, 2025 | SEC |
| Oct 7, 20255:58 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.20%7.59M shares | New | Oct 6, 2025 | SEC |
| Aug 14, 20258:51 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%478.9K shares | −5.00 ppfrom 9.99%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:45 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%471.9K shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Feb 14, 20255:17 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%285.4K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Palisade Bio, Inc. shares.
No Form 144 notices for Palisade Bio, Inc. are on file.